Biomerica (BMRA) Current Deferred Revenue (2012 - 2026)
Biomerica (BMRA) reported Current Deferred Revenue of $30000.0 for Q1 2026, down 45.45% on a YoY basis from $55000.0 in Q1 2025, and little changed sequentially from $30000.0 in Q4 2025.
Biomerica (BMRA) Current Deferred Revenue (2012 - 2026) Analysis & Trends
Biomerica (BMRA) has 14 years of Current Deferred Revenue data on file, last reported at $30000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Deferred Revenue fell 45.45% year-over-year to $30000.0; the trailing twelve-month figure through Feb 2026 stood at $30000.0 (down 45.45% YoY), and the FY2025 full-year result was $55000.0, down 35.29% from the prior year.
- Current Deferred Revenue held at $30000.0 in Q1 2026, from $30000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $3.2 million in Q1 2022 to a low of $30000.0 in Q4 2025.
- A 5-year average of $255623.6 and a median of $60000.0 in 2023 frame the typical range for Current Deferred Revenue.
- Across the five-year window, Current Deferred Revenue slumped 97.72% in 2022 and surged 41.67% in 2024, its largest moves.
- Tracing BMRA's Current Deferred Revenue over 5 years: stood at $49013.0 in 2022, then grew by 22.42% to $60000.0 in 2023, then surged by 41.67% to $85000.0 in 2024, then sank by 64.71% to $30000.0 in 2025, then changed by 0.0% to $30000.0 in 2026.
- Business Quant data shows BMRA's Current Deferred Revenue at $30000.0 in Q1 2026, $30000.0 in Q4 2025, and $54000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 30,000.00 |
| Nov 30, 2025 | 30,000.00 |
| Aug 31, 2025 | 54,000.00 |
| May 31, 2025 | 55,000.00 |
| Feb 28, 2025 | 55,000.00 |
| Nov 30, 2024 | 85,000.00 |
| Aug 31, 2024 | 85,000.00 |
| May 31, 2024 | 85,000.00 |
| Feb 29, 2024 | 85,000.00 |
| Nov 30, 2023 | 60,000.00 |
| Aug 31, 2023 | 60,000.00 |
| May 31, 2023 | 60,000.00 |
| Feb 28, 2023 | 138,013.00 |
| Nov 30, 2022 | 49,013.00 |
| Aug 31, 2022 | 150,523.00 |
| May 31, 2022 | 51,000.00 |
| Feb 28, 2022 | 3.21 Mn |
| Nov 30, 2021 | 2.15 Mn |
| May 31, 2019 | 37,971.00 |
| Feb 28, 2019 | 36,717.00 |